Almudena Aguilera-Saborido, Enrique Mercader Cidoncha, María Rosa Bella-Cueto, Isabel Gómez Muriel, José Vicente Méndez Monter, Jorge Gorrín Ramos, María Eugenia Torregrosa, Nieves López Lazareno, Jorge Francisco Gómez Cerezo, Patricia Martín Rojas-Marcos, Paola Parra Ramírez, Jorge Gabriel Ruiz-Sánchez, Marta Araujo-Castro, Esteban Poch, Felicia A Hanzu, Isabelle Runkle, Anna Oliveras, Josep Oriola
Journal: Endocrine 2024;85(2):532-544
PMID: 38507182
Primary aldosteronism (PA) is the most frequent cause of secondary hypertension and is associated with a higher cardiometabolic risk than essential hypertension. The aim of this consensus is to provide practical clinical recommendations for its surgical and medical treatment, pathology study and biochemical and clinical follow-up, as well as for the approach in special situations like advanced age, pregnancy and chronic kidney disease, from a multidisciplinary perspective, in a nominal group consensus approach of experts from the Spanish Society of Endocrinology and Nutrition (SEEN), Spanish Society of Cardiology (SEC), Spanish Society of Nephrology (SEN), Spanish Society of Internal Medicine (SEMI), Spanish Radiology Society (SERAM), Spanish Society of Vascular and Interventional Radiology (SERVEI), Spanish Society of Laboratory Medicine (SEQC(ML)), Spanish Society of Anatomic-Pathology and Spanish Association of Surgeons (AEC).
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.